Navigation Links
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Date:8/10/2008

MIAMI, Aug. 11 /PRNewswire/ -- Novis Pharmaceuticals, a leading distributor of biotherapeutic products to healthcare providers, announced today that John W. Kilgour has been named Executive Vice President of Sales and Marketing. John is a healthcare professional with thirty-five years of business and management experience in both pharmaceutical and medical/surgical supply chain distribution.

Recently retired from Cardinal Health, John held positions of increasing responsibility for more than 35 years and most recently served as Vice President of Sales in Cardinal's Pharmaceutical Supply Chain Program. Primary responsibilities included sales to Integrated Delivery Networks (IDNs) and particular emphasis on resource leadership, coaching and developing Cardinal's related sales groups. Other key positions within Cardinal Health included sales management to national and regional Group Purchasing Organizations (GPOs) as well as managing pharmaceutical and medical supply sales and marketing initiatives for the acute care and managed care business segments.

Tom Burke, President and CEO of Novis Pharmaceuticals, said, "John will be a great mentor and teacher for our employees and an even better advocate for our customers. He has established longstanding, solid relationships and has a reputation of going the extra mile for clients, employees, and especially patients. His knowledge of the industry is second to none and we consider ourselves very fortunate to have him as part of the Novis team."

"I am excited to be here," added John Kilgour. "I am very impressed with Novis' core competencies and the really exceptional people who work here. This is a talented, enthusiastic and energetic group dedicated to exceeding customer expectations while meeting important patient need. Simply stated, the 'customer relationship' and 'dedication to patient need' is paramount in all that we do."

"This is a very challenging time in our industry," he continued. "Healthcare Providers are facing increasingly complex and more challenging disease states. Novis' product scope, its reliability for authenticity and pedigree tracking competencies are consistent with new important patient safety industry initiatives.

Novis Pharmaceuticals is committed to providing extraordinary service to their customers and patients and provides time-sensitive, life-saving medications nationwide, 24 hours a day - 7 days a week.

For more information about Novis Pharmaceuticals, please visit http://www.novispharma.com .

About NOVIS Pharmaceuticals

Novis Pharmaceuticals is a leading national distributor of some of the world's leading plasma-derived products such as albumin, immune globulin, hyperimmunes and anti-hemophilic Factors VII, VIII and IX. Hospitals, home infusion therapy companies and other healthcare providers use these biotherapeutics to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions.


'/>"/>
SOURCE Novis Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
2. Novis Pharmaceuticals Hires Lisa Lopez
3. Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
4. Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link
5. Renovis Announces Management Changes
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
7. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
8. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
9. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
10. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
11. Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March 26-28 ... coding audit process for all medical chart types with a comprehensive set of ...
(Date:3/23/2017)... ... ... Journey Through Heaven”: the true-life account of a man who faced death and emerged ... for His people. “My Journey Through Heaven” is the creation of published author Earl ... grandchildren living and doing for God as best they can. , Published by Christian ...
(Date:3/23/2017)... ... ... simple and strong explanation of the God’s love. “More Corruption” is the creation of published ... to write a book about Him. , She says, “I’m fed up with mortals misjudging ... Lord God. They have not walked in my shoes and I know they never could ...
(Date:3/22/2017)... ... March 23, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had won the ‘Clinical Supply ... the Suntec Singapore International Exhibition & Convention Centre, Singapore. The award was presented ...
(Date:3/22/2017)... ... , ... Old School Labs™, makers of the best-selling Vintage line of natural ... Theophane, who trained with Floyd Mayweather, made his professional debut in London in 2003 ... impressive number of wins in contests in Britain, Germany and the U.S. , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Sweden , Mar 23, 2017 ... medicine company, today announced that the English version of the ... website www.neurovive.com .  ... About NeuroVive NeuroVive Pharmaceutical AB ... to the discovery and development of medicines that preserve mitochondrial ...
(Date:3/22/2017)... DUBLIN , Mar. 22, 2017 Research ... Care Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 10.9% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/22/2017)... 22, 2017 Under the impetus of ... market size increased year by year at the ... 2021, the market size will maintain the growth ... outnumber RMB140 billion in 2021, thanks to severe ... of biological agents and supporting policies. At ...
Breaking Medicine Technology: